Researchers develop a protein called NAP which protects and restores nerve cell communication in some neurodegenerative diseases.
A test that uses images of cats and dogs may prove to be a quick and effective method of predicting which patients in early stages of Parkinson's disease will develop dementia.
Natural killer cells may play a critical role in regulating and restraining neuroinflammation and protein clumping associated with Parkinson's disease.
Study reveals a new mechanism that appears to reverse the build-up of protein aggregates by refolding them, rather than removing them.
Researchers have identified a mechanism that may explain how neurons falter during the earliest stages of Alzheimer's and other neurodegenerative diseases.
The Parkinson's-associated protein alpha-synuclein appears to act as a "toggle switch" that helps control vesicle transportation and gene expression. In a diseased state, this delicate balance is broken. The findings have implications for the development of new treatments for Parkinson's disease.
A protein associated with Parkinson's disease regulates neurotransmission by self association, a new study reports.
Researchers explore how people with Parkinson's disease make use of online, virtual reality environments.
Researchers improve both animal and cell models for Parkinson's disease, a new study reports.
Researchers have developed a new biomarker that will enable a rapid and inexpensive test for Parkinson's disease.
Researchers have developed a sensor that can detect early stage Parkinson's disease by analyzing a sample of a patient's breath.
Researchers report EEG technology has the ability to study activity of areas deep inside the brain, such as the thalamus and nucleus accumbens. The findings will help shed new light on disorders that affect these brain regions, such as Parkinson's disease and OCD.
